DECODING THE SANOFI PASTEUR DENGUE VACCINE INFECTIVITY AND IMMUNOGENICITY USING THE HUMAN IN VITRO MIMIC® SYSTEM

被引:0
|
作者
Luna, Ernesto [1 ]
Chehtane, Mounir [1 ]
Agrawal, Pankaj [1 ]
Mehta, Riyaz [1 ]
Byers, Anthony [1 ]
Schanen, Brian [1 ]
Guy, Bruno [2 ]
Jackson, Nicholas [2 ]
Warren, William [1 ]
Moser, Janice M. [1 ]
机构
[1] Sanofi Pasteur, Orlando, FL USA
[2] Sanofi Pasteur, Lyon, France
来源
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2017年 / 95卷 / 05期
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
1362
引用
收藏
页码:428 / 428
页数:1
相关论文
共 50 条
  • [31] Enhanced immunogenicity and protective efficacy of a tetravalent dengue DNA vaccine using electroporation and intradermal delivery
    Williams, Maya
    Ewing, Dan
    Blevins, Maria
    Sun, Peifang
    Sundaram, Appavu K.
    Raviprakash, Kanakatte S.
    Porter, Kevin R.
    Sanders, John W.
    VACCINE, 2019, 37 (32) : 4444 - 4453
  • [32] A RANDOMIZED, OBSERVER-BLINDED, PHASE I STUDY TO ASSESS THE SAFETY AND IMMUNOGENICITY OF VI-DT CONJUGATE VACCINE COMPARED TO VI-POLYSACCHARIDE (TYPHIM VI®, SANOFI PASTEUR) TYPHOID VACCINE IN HEALTHY FILIPINO ADULTS AND CHILDREN
    Tesema, Samuel
    Sahastrabuddhe, Sushant
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 143 - 144
  • [33] An in vitro evaluation of Candida tropicalis infectivity using human cell monolayers
    Negri, Melyssa
    Botelho, Claudia
    Silva, Sonia
    Reis Henriques Lopes, Luis Miguel
    Henriques, Mariana
    Azeredo, Joana
    Oliveira, Rosario
    JOURNAL OF MEDICAL MICROBIOLOGY, 2011, 60 (09) : 1270 - 1275
  • [34] Analysis of a live attenuated bacterial vaccine for tularemia in the MIMIC® (Modular Immune In vitro Construct) System
    Moser, Janice
    Sassano, Emily
    Muerrle, Christopher
    Waag, David
    Wittman, Vaughan
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [35] Immunogenicity of the CYD tetravalent dengue vaccine using an accelerated schedule: randomised phase II study in US adults
    Judith Kirstein
    William Douglas
    Manoj Thakur
    Mark Boaz
    Thomas Papa
    Anna Skipetrova
    Eric Plennevaux
    BMC Infectious Diseases, 18
  • [36] Immunogenicity of the CYD tetravalent dengue vaccine using an accelerated schedule: randomised phase II study in US adults
    Kirstein, Judith
    Douglas, William
    Thakur, Manoj
    Boaz, Mark
    Papa, Thomas
    Skipetrova, Anna
    Plennevaux, Eric
    BMC INFECTIOUS DISEASES, 2018, 18
  • [37] The Preparation of Human Papillomavirus Type 58 Vaccine and Exploring Its Biological Activity and Immunogenicity In Vitro
    Deng, Dongrui
    Liao, Shujie
    Bai, Xiangyang
    Wang, Wei
    Sima, Ni
    Xu, Qian
    Zhu, Tao
    Xu, Gang
    Zhou, Jianfeng
    Wang, Shixuan
    Meng, Li
    Ma, Ding
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (06) : 988 - 995
  • [38] Decoding the Human Immune System to Accelerate Next Generation Vaccine and Immunotherapy Development
    Koff, W.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 260 - 260
  • [39] PATTERNED HUMAN EPIDERMAL VITRO MODEL USING BIOPRINTING TO MIMIC HETEROGENEITY OF HUMAN SKIN
    Rielland, Maite
    Madiedo-Podvrsan, Sabrina
    Belaidi, Jean-Philippe
    Desbouis, Stephanie
    Ben Khalifa, Youcef
    Simonetti, Lucie
    Soeur, Jeremie
    TISSUE ENGINEERING PART A, 2022, 28 : S471 - S471
  • [40] In vitro immunogenicity evaluation of antibody therapeutics using primary human cells
    Inoue, Tomoaki
    Kubo, Chiyomi
    DRUG METABOLISM REVIEWS, 2011, 43 : 11 - 11